Giulia Zoccai

eremita per scelta,compagni privilegiati : arte, botanica creatività e fantasia. Esperto d'arte x tribunale,Camere di Commercio e Mostre

[Bernard Kadosh @KadoshBernard]

Friends. It’s 2024 and the interns are still holding the beta blocker on admission.

Sometimes medical education is like screaming in the subway. Loud, repetitive, completely ineffective. 🆘 @MKIttlesonMD @gcfmd

[Monique @mzu2013]

Believe in yourself, push your limits, experience life, conquer your goals, and be happy. 💗

Happy Wednesday 😘🌸🦋🍀

#WednesdayMotivation

[Giulia Zoccai @giuliazoccai]

@mzu2013 Be happy you too

[Giulia Zoccai @giuliazoccai]

@c12345xd Very. Nice

[Museo Poldi Pezzoli @PoldiPezzoli]

Realizzati a partire da vere foglie con l'antica tecnica della fusione a cera persa. #Vendorafa per #Gioiello.

[AntonioAbbate @AbbateAntonio]

What a wonderful opportunity to have @JJheart_doc visit @CardioUva and teach us about biomarkers and heart failure. Thank you Jim! @uvamedicine @UVACVRC

[EHJ Editor-in-Chief @ehj_ed]

Earlier diagnosis of AF is associated with a higher hazard ratio of subsequent myocardial disease and shorter life expectancy. Read more in #EHJ
#atrialfibrillation #CardioTwitter @escardio @ESC_Journals

https://t.co/zs1qpjbiz0

[Francesco Paneni @FrancescoPaneni]

Happy to share our position paper from the ESH WG on Small Arteries. If you want to learn more about vascular inflammation, this is the right paper for you🔥❤️👇https://t.co/K8V5A4n1uq A special thank to F. Rios and A. Virdis! @HyperAHA @CTECresearch @Unipisa

[Roberto Burioni @RobertoBurioni]

Da medico "stagionato", vedere dopo una terapia la completa regressione di un tumore metastatico è l'apparizione di un prodigio.
Decenni di vita che di colpo si aprono per il malato, che forse non è più malato.
Una volta era Lourdes, oggi è scienza.
E qualcuno ci sputa sopra.

[Dr. Glaucomflecken @DGlaucomflecken]

There is nothing quite like match day. This is the only photo I have from my match day (taken with the first phone camera in existence, apparently). Congratulations everybody! Take plenty of non-blurry pictures!

[EuroIntervention @EuroInterventio]

This bench study suggested that BVF performed after ViV offers the largest haemodynamic benefit without any long-term trade-offs in terms of THV performance or structural valve damage. #EIJBestOf https://t.co/AjAuV59O33

[Brittany Weber @Bweber04]

@AbbateAntonio @CardioUva @ChrisKramerMD @UVACVRC Amazing!! Congratulations @AbbateAntonio !

[AntonioAbbate @AbbateAntonio]

I received a beautiful gift from Dr. George Beller ⁦@CardioUva⁩ today - a picture of Ms. Ruth C. Heede who established the endowed professorship that Dr. Beller and ⁦@ChrisKramerMD⁩ held before me. ⁦@UVACVRC⁩

[Davide Capodanno @DFCapodanno]

Can we clear arterial atherosclerotic plaques?

The ACC.24 Late-Breaking Clinical Trials have been announced. My highlight is the large, phase 3, multicenter, double-blind, randomized, placebo-controlled AEGIS-II trial, a study of CSL112 (apolipoprotein A-I) infusion in patients with acute myocardial infarction.

Cholesterol efflux, mediated by apolipoprotein A-I, removes excess cholesterol from atherosclerotic plaque and transports it to the liver for excretion. CSL112 increases cholesterol efflux capacity.

A target sample of >18,000 participants will be randomized 1:1 to receive 4 weekly infusions of CSL112 6 g or placebo, initiated prior to or on the day of discharge and within 5 days of first medical contact.

The primary outcome is the time to first occurrence of the composite of cardiovascular death, myocardial infarction, or stroke through 90 days.

Why do I find it so interesting? AEGIS-II will be the first trial to formally test whether enhancing cholesterol efflux can reduce the rate of recurrent major adverse cardiovascular events.

https://t.co/7nKG7yJIfd

[Davide Capodanno @DFCapodanno]

This prospective, observational, all-comers study describes the real-world management of patients with severe symptomatic aortic stenosis in a population of nearly 3 million Northern Europeans in the context of the latest European guidelines for the treatment of valvular heart disease. https://t.co/dnnPApeGYe

[Roberto Porta @RobertoPorta7]

A piedi nel bosco sotto la neve

[Fornarina @fornarina_art]

おはようございます🌹良い一日を✨